Prescription Medications With Actionable Pharmacogenomic Recommendations in Veterans Health Administration Patients
Pharmacogenomics · 2023
DOI: 10.2217/pgs-2023-0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacogenomics, 2023. Verfasst von Saba Maghari und 8 weiteren Autor:innen. Beteiligte Einrichtung: Phoenix VA Health Care System, Phoenix, AZ 85012, USA. Hauptthemen laut MEDLINE: Prescription Drugs, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Aim
To evaluate the prevalence of medications with actionable pharmacogenomic (PGx) safety and efficacy recommendations in patients receiving care from the Veterans Health Administration. Materials & methods: Outpatient prescription data from 2011 to 2021 and any documented adverse drug reactions (ADRs) were reviewed for those who received PGx testing at one Veterans Administration location between November 2019 and October 2021.
Results
Among the reviewed prescriptions, 381 (32.8%) were associated with an actionable recommendation based on the Clinical Pharmacogenetics Implementation Consortium (CPIC) prescribing guidelines, with 205 (17.7%) for efficacy concerns and 176 (15.2%) for safety concerns. Among those with a documented ADR for a PGx-impacted medication, 39.1% had PGx results that aligned with CPIC recommendations.
Conclusion
Medications with actionable PGx recommendations for safety and efficacy concerns are received with similar frequency, and most patients who have undergone PGx testing at the Phoenix Veterans Administration have received medications that may be impacted by PGx testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Phoenix VA Health Care System, Phoenix, AZ 85012, USA.
- University of Arizona, College of Medicine-Phoenix, Phoenix, AZ 85004, USA.
ORCID-Profile: Saba Maghari
Zitieren
APA
Maghari, S., Gallo, T., Rivas, S., German, A., Nguyen Le, M. Q., Abbaszadegan, H., Zubriski, M. A., Heise, C. W., & Landas, N. D. (2023). Prescription Medications With Actionable Pharmacogenomic Recommendations in Veterans Health Administration Patients. Pharmacogenomics. https://doi.org/10.2217/pgs-2023-0018
Vancouver
Maghari S, Gallo T, Rivas S, German A, Nguyen Le MQ, Abbaszadegan H, et al. Prescription Medications With Actionable Pharmacogenomic Recommendations in Veterans Health Administration Patients. Pharmacogenomics. 2023. doi:10.2217/pgs-2023-0018
BibTeX
@article{Maghari2023,
author = {Maghari, Saba and Gallo, Tyler and Rivas, Salvador and German, Alexander and Nguyen Le, Minh Q and Abbaszadegan, Hamed and Zubriski, Mark A and Heise, Craig W and Landas, Noel D},
title = {Prescription Medications With Actionable Pharmacogenomic Recommendations in Veterans Health Administration Patients},
journal = {Pharmacogenomics},
year = {2023},
doi = {10.2217/pgs-2023-0018}
}
EUVIMED